Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Clinical trial NCT05237258 · RECRUITING

Trial details

NCT number: NCT05237258
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Relapsed Adult AML Primary Refractory Acute Myeloid Leukemia High Risk Acute Myeloid Leukemia

Start date: 2022-06-01
Primary completion: 2028-04-01
Enrollment: 2300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.